Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples

NCT02795975 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1766

Last updated 2017-03-24

No results posted yet for this study

Summary

The objective of this study is to evaluate the performance characteristics of the AC2 assay on the Panther system using female urine specimens.

Conditions

  • Chlamydia Trachomatis
  • Gonorrhea

Sponsors & Collaborators

  • Hologic, Inc.

    lead INDUSTRY

Eligibility

Min Age
14 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-03-01
Completion
2017-03-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02795975 on ClinicalTrials.gov